Pierre Fabre
| Primary URL | Location | Industry | www[.]pierre-fabre[.]com |
Country
France
|
Pharmaceuticals
|
|---|
Profile
PierreFabre is a French multinational company that operates in the pharmaceutical and dermocosmetics sectors. Its pharmaceutical activities include the development, production and marketing of prescription medicines and over‑the‑counter health products. In the dermocosmetics field the group markets well‑known brands such as Avène, Ducray, Galénic, Klorane and René Furterer. These products are distributed through pharmacies, parapharmacies and specialized retail channels in many countries. The company serves patients, consumers and healthcare professionals seeking therapeutic and skin‑care solutions.
Pierre Fabre maintains a global footprint with subsidiaries and distribution networks in more than one hundred countries. Its headquarters are located in Castres, France, where the original laboratories were founded. The group employs a substantial workforce that supports research, manufacturing and commercial functions across its various sites. This international presence enables the company to adapt its offerings to diverse regulatory environments and market needs.
A distinguishing characteristic of Pierre Fabre is its integrated approach that links pharmaceutical research with dermocosmetic expertise, particularly in dermatology and oncology. The company operates dedicated research centers that focus on active ingredients derived from botanical sources and on innovative drug delivery systems. It also places a strong emphasis on sustainable development, implementing eco‑responsible practices in its manufacturing and packaging processes. The 2021 ransomware attack that halted production and led to the leak of internal documents highlighted the importance of cybersecurity resilience for the organization.
Pierre Fabre remains a privately held, family‑owned enterprise, with the Fabre family retaining control of the group's strategic direction. Its organizational structure includes distinct divisions such as Pierre Fabre Médicament for pharmaceuticals and Pierre Fabre Dermo‑Cosmétique for dermocosmetics. These subsidiaries allow focused management while benefiting from shared resources and synergies across the group.
